Detection of minimal residual disease by mutant p53 immunocytochemistry in acute myelogenous leukemia

Med Pediatr Oncol. 2000 Feb;34(2):153-6. doi: 10.1002/(sici)1096-911x(200002)34:2<153::aid-mpo18>3.0.co;2-q.

Authors

A C Kattamis¹, G T Tsangaris, J Vamvoukakis, M Moschovi, S Grafakos, F Tzortzatou-Stathopoulou

Affiliation

¹ Oncology Unit, First Department of Pediatrics, Athens University, 'Aghia Sophia' Children's Hospital, Athens, Greece.

PMID: 10657882
DOI: 10.1002/(sici)1096-911x(200002)34:2<153::aid-mpo18>3.0.co;2-q

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Genes, p53 / genetics*
Humans
Immunohistochemistry
Leukemia, Myeloid, Acute / genetics*
Leukemia, Myeloid, Acute / pathology*
Male
Mutation
Recurrence